Back to Agenda
The Journey to a Modernization of Analytics
Session Chair(s)
Peter Mesenbrink, PHD
Executive Director of Biostatistics, Novartis Pharmaceuticals Corporation, United States
This forum will present on the statistical analytics assessment framework based on risk as to the factors that contribute to confidence or trust for various statistical software, tools, and applications. A panel of experts will provide their experiences.
Learning Objective : Describe best practices to achieve a modernization of analytics within biostatistics and data science.
Speaker(s)
Peter Mesenbrink, PHD
Executive Director of Biostatistics, Novartis Pharmaceuticals Corporation, United States
Changing How We Use Modern Analytics in Clinical Drug Development
Daniel Woodie, MS
Senior Scientist, Statistical Programming, Merck & Co., Inc., United States
Industry Update
Andy Nicholls, MSC
Senior Director, Head of Statistical Data Sciences, GlaxoSmithKline, United Kingdom
Industry Update
Min Lee
Director of Biostatistical Programming , Amgen, United States
Industry Update
Have an account?